Valmark Advisers, Inc.
Q2 2014 13F-HR Holdings
Net value change ($000)
+281,958
(7.2%)
New positions
2
Sold out positions
2
Turnover %
0.0%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q1 2014
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| IVE | 106,903 | 28.6% |
| VEU | 37,908 | 7.7% |
| IVW | 32,597 | 7.9% |
| TDTT | 17,415 | 5.8% |
| VWO | 13,569 | 8.7% |
| LQD | 11,324 | 6.3% |
| HYG | 11,297 | 6.8% |
| GUNR | 10,406 | 9.2% |
| RWX | 10,289 | 9.1% |
| IJR | 9,375 | 2.8% |
Top Reduces (Value $000, Stocks/ETFs)
| IJH | -37,929 | -9.8% |
| LIBERATOR MEDICAL HLDGS INC | -257 | -100.0% |
| SHY | -213 | -2.7% |
| HYS | -81 | -1.9% |
| SPDR SERIES TRUST | -76 | -9.6% |
| GNR | -40 | -1.9% |
| XOM | -40 | -10.9% |
| CESCA THERAPEUTICS INC | -37 | -100.0% |
| IBM | -20 | -6.0% |
| PFF | -10 | -1.9% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|